(CNYA) iShares MSCI China - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46434V5140 • China Region
CNYA: Chinese, Stocks, Equities, A-Shares
The iShares MSCI China A ETF (BATS:CNYA) is designed to track the performance of the MSCI China A Index, which focuses on A-shares listed on the Shanghai and Shenzhen stock exchanges. These shares are accessible to foreign investors through the Shanghai-Hong Kong Stock Connect and Shenzhen-Hong Kong Stock Connect programs. The fund typically allocates at least 80% of its assets to securities in its underlying index or to investments with similar economic characteristics, ensuring close alignment with the indexs performance. This ETF provides exposure to a broad range of sectors within the Chinese economy, offering a diversified approach to investing in Chinas domestic equity market.
From a technical perspective, CNYA has shown a short-term uptrend, with its 20-day moving average (SMA 20) at 28.05 slightly above its current price of 27.96. The 50-day moving average (SMA 50) at 27.78 and the 200-day moving average (SMA 200) at 26.83 indicate a longer-term bullish trend. The Average True Range (ATR) of 0.34 reflects moderate volatility, while the average 20-day volume of 127,931 shares suggests moderate liquidity. These metrics collectively point to a stable trading environment with potential for incremental growth.
With assets under management (AUM) of $221.11 million, CNYA is a moderately sized ETF, providing a balance between liquidity and diversification. Its focus on A-shares offers exposure to Chinas domestic economy, which has been driven by policy reforms and technological advancements. The funds structure allows it to capture the performance of key sectors in China, including financials, technology, and consumer goods, making it a relevant choice for investors seeking targeted exposure to the Chinese market.
Over the next three months, CNYA is expected to maintain its upward trajectory, supported by the strengthening fundamentals of Chinas domestic market. The technical indicators suggest a potential price target of 29.50, with manageable volatility levels. The funds AUM is projected to grow modestly, reflecting increased investor interest in Chinas economic recovery and sector-specific growth opportunities.
Additional Sources for CNYA ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CNYA ETF Overview
Market Cap in USD | 210m |
Category | China Region |
TER | 0.60% |
IPO / Inception | 2016-06-13 |
CNYA ETF Ratings
Growth Rating | -7.93 |
Fundamental | - |
Dividend Rating | 51.4 |
Rel. Strength | -1.2 |
Analysts | - |
Fair Price Momentum | 25.76 USD |
Fair Price DCF | - |
CNYA Dividends
Dividend Yield 12m | 2.58% |
Yield on Cost 5y | 2.74% |
Annual Growth 5y | 9.32% |
Payout Consistency | 88.8% |
CNYA Growth Ratios
Growth Correlation 3m | -29.5% |
Growth Correlation 12m | 53.2% |
Growth Correlation 5y | -68.4% |
CAGR 5y | 1.27% |
CAGR/Max DD 5y | 0.03 |
Sharpe Ratio 12m | -0.69 |
Alpha | 2.13 |
Beta | 0.357 |
Volatility | 18.31% |
Current Volume | 210.6k |
Average Volume 20d | 120.5k |
As of April 25, 2025, the stock is trading at USD 27.29 with a total of 210,599 shares traded.
Over the past week, the price has changed by +1.75%, over one month by -3.57%, over three months by -1.80% and over the past year by +8.23%.
Neither. Based on ValueRay Analyses, iShares MSCI China is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of -7.93 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CNYA as of April 2025 is 25.76. This means that CNYA is currently overvalued and has a potential downside of -5.61%.
iShares MSCI China has no consensus analysts rating.
According to ValueRays Forecast Model, CNYA iShares MSCI China will be worth about 28.1 in April 2026. The stock is currently trading at 27.29. This means that the stock has a potential upside of +3%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 28.1 | 3% |